FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for bimatoprost from Apotex Corp., authorizing a regulatory change under the ANDA framework.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotrichosis of the Eyelashes
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

SUPPL AP for BIMATOPROST (BIMATOPROST)